关于铁在异常性帕金森病中的作用
Sandro Huenchuguala1, Juan Segura-Aguilar2
1Escuela de Tecnología Médica, Facultad de Salud, Universidad Santo Tomás, Santiago 8370003, Chile.
Biomedicines
|November 25, 2023
概括
铁对人类生命至关重要,但过量或不足会导致疾病. 一项研究表明,铁可能不是帕金森病的核心.
科学领域:
- 生物化学 生物化学
- 神经科学是一个神经科学.
- 人体生理学 人体生理学
背景情况:
- 铁是一种过渡金属,对氧气运输 (血红蛋白) 和细胞能量 (ATP合成) 至关重要.
- 铁的稳定性至关重要,因为缺乏和多余的铁都与各种病理有关.
- 帕金森病 (PD) 大脑中的铁沉积表明它在神经退行中起作用,但这是有争议的.
研究的目的:
- 研究铁在帕金森病退行性过程中的作用.
- 为了评估铁化疗在帕金森病患者的疗效.
主要方法:
- 临床研究涉及帕金森病患者.
- 使用铁化剂德费里的管理.
- 评估临床症状和疾病进展.
主要成果:
- 铁化剂deferiprone在帕金森病患者中没有表现出积极的影响.
- 用德费里治疗的患者的临床症状恶化.
- 这项研究挑战了铁在帕金森病神经退行症中起着基本作用的假设.
结论:
- 铁可能不是帕金森病退行过程的主要因素.
- 需要进一步的研究来了解铁在神经系统疾病中的复杂作用.
- 这些发现表明,在治疗帕金森病时使用铁化剂应谨慎.
关键词:
这是一个MPTPTPMPTP.帕金森病是帕金森氏症的一种疾病.化剂 化剂是一种化剂.这种药物是deferiprone.多巴胺是多巴胺的一种.铁是铁,铁是铁,铁是铁.神经退行症的神经退行症神经黑色素是一种神经黑色素.神经保护神经保护氧化应激是一种氧化应激.更多相关视频
06:07Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease
Published on: June 23, 2023
1.6K
08:09Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease
Published on: January 7, 2014
7.6K
相关概念视频
Parkinson's Disease: Treatment
276
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
276
Parkinson's Disease: Overview
557
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
557
Neural Regulation
39.5K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.5K
EPS and iPS Cells in Disease Research
2.8K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.8K
Lysosomal Hydrolases
3.8K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.8K
